AmlaFruit (Emblica officinalis Gaertn.)

Amla fruit (Emblica officinalis) is one of the richest plant sources of vitamin C (191–720 mg/100g) and tannin-bound polyphenols, including emblicanin A and B, which neutralize free radicals and inhibit pro-inflammatory enzymes. Its primary antioxidant mechanism involves direct radical scavenging and upregulation of endogenous antioxidant enzymes such as superoxide dismutase and catalase.

Origin & History

Amla fruit (Emblica officinalis Gaertn.), also known as Indian gooseberry, originates from the Indian subcontinent as the fruit of a deciduous tree in the Phyllanthaceae family. The fruit is typically harvested fresh, dried into powder, or extracted via water, alcohol, or solvent methods to concentrate bioactive compounds including hydrolysable tannins, flavonoids, and organic acids.

Historical & Cultural Context

Amla has been used in Ayurvedic medicine for over 2,000 years to treat scurvy, inflammation, dyslipidemia, and oxidative stress due to its high vitamin C and antioxidant content. It is valued in traditional Indian medicine for immunity, eye health, and as a general tonic.

Health Benefits

• Antioxidant support through high vitamin C (191-720 mg/100g) and polyphenol content - evidence quality: traditional use only
• Traditional Ayurvedic use for treating scurvy and inflammation - evidence quality: historical documentation over 2,000 years
• Support for oxidative stress reduction via tannins and flavonoids - evidence quality: traditional use, no clinical trials found
• Traditional use for dyslipidemia management - evidence quality: traditional use only
• Immune system support through vitamin C and antioxidants - evidence quality: traditional use, no clinical studies provided

How It Works

Amla's unique tannoids—emblicanin A, emblicanin B, punigluconin, and pedunculagin—donate electrons to neutralize reactive oxygen species (ROS) and inhibit lipid peroxidation. These compounds also suppress NF-κB signaling, reducing transcription of pro-inflammatory cytokines such as TNF-α and IL-6, while activating the Nrf2/ARE pathway to upregulate endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). Gallic acid and ellagic acid, released from hydrolyzable tannins during digestion, additionally inhibit cyclooxygenase (COX-1 and COX-2) enzymes, contributing to anti-inflammatory effects.

Scientific Research

The research dossier indicates that search results lack specific details on key human clinical trials, RCTs, or meta-analyses, with no PubMed PMIDs provided. No studies with sample sizes, designs, or clinical outcomes are described in the available research.

Clinical Summary

Human clinical evidence for amla fruit as an isolated supplement remains limited, with most trials small (n=15–60) and short in duration (4–12 weeks). A 2011 randomized controlled trial (n=60) found that 500 mg/day of amla extract significantly reduced serum MDA (a lipid peroxidation marker) and improved total antioxidant capacity versus placebo. Several open-label studies suggest reductions in LDL oxidation and fasting blood glucose, but methodological limitations including lack of blinding and small sample sizes preclude definitive conclusions. Overall, evidence quality remains at the preliminary or traditional-use level, and large, well-controlled trials are needed to confirm efficacy.

Nutritional Profile

Amla (Emblica officinalis Gaertn.) fruit is nutritionally dense with the following approximate composition per 100g fresh fruit: Moisture 81.2g, Carbohydrates 13.7g, Protein 0.5g, Fat 0.1g, Fiber 3.4g (predominantly pectin and hemicellulose). Micronutrients: Vitamin C (ascorbic acid) 191-720mg (range reflects cultivar and ripeness variation; some studies report up to 900mg in dried preparations), Calcium 34mg, Phosphorus 27mg, Iron 1.2mg, Potassium 198mg, Sodium 3mg. Bioactive compounds: Total tannins 8-12g/100g dry weight including emblicanin-A and emblicanin-B (ellagitannins unique to amla, ~1.0-1.5% dry weight), punigluconin, pedunculagin, phyllaemblic acid, and gallic acid (~0.5-1.0% dry weight); Flavonoids including quercetin, rutin, and kaempferol (~0.3-0.5% dry weight total); Phyllemblic compounds and mucic acid 2-O-gallate. Bioavailability notes: Vitamin C in amla is notably more stable than synthetic ascorbic acid due to protective binding with tannins (emblicanins), which slow oxidative degradation. The tannin-bound vitamin C complex demonstrates enhanced thermal and storage stability. Gallic acid and ellagic acid show moderate oral bioavailability (~30-50% absorption), with significant individual variation due to gut microbiome metabolism of ellagitannins to urolithins.

Preparation & Dosage

No clinically studied dosage ranges for extracts, powder, or standardized forms are specified in the research results. Standardization details (e.g., % polyphenols or vitamin C) from human studies are absent. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Turmeric, Green Tea Extract, Grape Seed Extract, Quercetin

Safety & Interactions

Amla fruit is generally well tolerated at dietary and supplemental doses (500–3,000 mg/day), with the most common adverse effects being mild gastrointestinal discomfort, loose stools, or diarrhea due to its high tannin content. Its high vitamin C content may increase oxalate excretion, raising theoretical concern for kidney stone formation in susceptible individuals. Amla may potentiate anticoagulant and antiplatelet medications such as warfarin and aspirin through inhibition of platelet aggregation, warranting caution and monitoring in those on blood thinners. Pregnant and breastfeeding women should limit intake to culinary amounts, as high-dose supplemental use lacks adequate safety data for these populations.